Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen‐induced arthritis
Tóm tắt
Mesenchymal stem cells (MSCs) are precursors of tissue of mesenchymal origin, but they also have the capacity to regulate the immune response by suppressing T and B lymphocyte proliferation in a non–major histocompatibility complex–restricted manner. Use of MSCs as immunosuppressant agents in autoimmune diseases has been proposed and successfully tested in animal models. We explored the feasibility of using allogeneic MSCs as therapy for collagen‐induced arthritis, a mouse model for human rheumatoid arthritis.
DBA/1 mice were immunized with type II collagen in Freund's complete adjuvant, and some of the animals received an intraperitoneal injection of allogeneic MSCs.
A single injection of MSCs prevented the occurrence of severe, irreversible damage to bone and cartilage. MSCs induced hyporesponsiveness of T lymphocytes as evidenced by a reduction in active proliferation, and modulated the expression of inflammatory cytokines. In particular, the serum concentration of tumor necrosis factor α was significantly decreased. MSCs exerted their immunomodulatory function by educating antigen‐specific Tregs.
Our results suggest an effective new therapeutic approach to target the pathogenic mechanism of autoimmune arthritis using allogeneic MSCs. However, further studies are required before these results can be translated to clinical settings.
Từ khóa
Tài liệu tham khảo
Maccario R, 2005, Interaction of human mesenchymal stem cells with cells involved in alloantigen‐specific immune response favors the differentiation of CD4+ T‐cell subsets expressing a regulatory/suppressive phenotype, Haematologica, 90, 516
Ishida T, 1994, Requirement of donor‐derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation: complete prevention of recurrence of autoimmune diseases in MRL/MP‐lpr/lpr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor, J Immunol, 152, 3119, 10.4049/jimmunol.152.6.3119
Ciubotariu R, 1998, Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28− regulatory T cells, J Immunol, 161, 5193, 10.4049/jimmunol.161.10.5193
Seki N, 1992, Type II collagen‐induced murine arthritis: induction of arthritis depends on antigen‐presenting cell function as well as susceptibility of host to an anticollagen immune response, J Immunol, 148, 3093, 10.4049/jimmunol.148.10.3093